ADAM17 and familial dilated cardiomyopathy: The main finding of our study was that the combination of ADAM17 knockdown and eplerenone treatment can protect the heart by reversing left ventricular remodeling and dysfunction without changing blood pressure, blood glucose, or potassium levels in DCM mice.